The use of a novel TIMP3 peptide to specifically target therapeutic drugs to tumours
Main Author: | Aldughaim, Mohammed |
---|---|
Other Authors: | Barker, Mike |
Published: |
University of Sheffield
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.737888 |
Similar Items
-
Specific Targeting of PEGylated Liposomal Doxorubicin (Doxil<sup>®</sup>) to Tumour Cells Using a Novel TIMP3 Peptide
by: Mohammed S. Aldughaim, et al.
Published: (2021-12-01) -
Coupling of a Novel TIMP3 Peptide to Carboxypeptidase G2 for Pro-Drug Activation at the Tumour Site
by: Mohammed S. Aldughaim, et al.
Published: (2021-01-01) -
Therapeutic targets in neuroendocrine tumours
by: Kostoula, V.
Published: (2010) -
The tumour microenvironment as a potential therapeutic target in breast cancer
by: Haider, Marie-Therese
Published: (2016) -
TIMP-3 as a therapeutic target for cancer
by: Chun-Wen Su, et al.
Published: (2019-07-01)